Effect of Paricalcitol on Bone Density After Kidney Transplantation: Analysis of 2 Transplant Centers.
CONCLUSIONS: Paricalcitol is an effective therapy for secondary hyperparathyroidism in kidney transplant recipients.
PMID: 29190607 [PubMed - in process]
Source: Iranian Journal of Kidney Diseases - Category: Urology & Nephrology Tags: Iran J Kidney Dis Source Type: research
More News: Calcium | Chronic Kidney Disease | Hormones | Hyperparathyroidism | Iran Health | Kidney Transplant | Kidney Transplantation | Middle East Health | Phosphorus | Prednisone | Proteinuria | Transplant Surgery | Transplants | Urology & Nephrology | Vitamin D | Vitamins